Clinical Trial Update: A Phase III Study to Evaluate the Efficacy, Immunogenicity and Safety of the 9-valent HPV Vaccine in Chinese Males [Phase 3]

View source ↗

Summary

Phase III trial in Chinese males evaluating the efficacy, immunogenicity and safety of the 9-valent HPV vaccine for HPV-related diseases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anal Cancer
• Anal Intraepithelial Neoplasia
• Genital Warts
• Hpv-associated Carcinoma
• Penile Cancer
• Penile Intraepithelial Neoplasia

Drugs mentioned

• Gardasil 9 (Human papillomavirus vaccine, 9-valent)

Snippet

Sponsor: Shanghai Bovax Biotechnology Co., Ltd. | Conditions: Genital Wart, Penile Cancer | Phase 3 | Status: ACTIVE_NOT_RECRUITING